Area of research
Biomedical Engineering · Biomaterials
Research interest
Research interests include Nanoplatforms for cancer theranostics, Nanoparticle-Based Drug Delivery, RNA Interference and Gene Delivery, and Cancer Immunotherapy and Biomarkers.
Rational development of gemcitabine-based nanoplatform for targeting SERPINB9/Granzyme B axis to overcome chemo-immune-resistance.
Cancer Cell Membrane-Coated NPs as a Biomimetic Strategy for Precision Tumor Therapy.
Modulating immune cells within pancreatic ductal adenocarcinoma via nanomedicine.
YAP/TAZ Inhibitor-Based Drug Delivery System for Selective Tumor Accumulation and Cancer Combination Therapy.
Polymer-Based Drug Delivery Systems for Cancer Therapeutics.
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy.
In Situ Formation of Fibronectin-Enriched Protein Corona on Epigenetic Nanocarrier for Enhanced Synthetic Lethal Therapy.
Progress on oxygen-releasing bioactive polymeric scaffolds in tissue engineering and biomedical treatment: A review
miR-31-5p Is a Potential Circulating Biomarker and Therapeutic Target for Oral Cancer
A Nanomicellar Prodrug Carrier Based on Ibuprofen-Conjugated Polymer for Co-delivery of Doxorubicin
Oleic acid induces apoptosis and autophagy in the treatment of Tongue Squamous cell carcinomas